[ad_1] Go Digit General Insurance has purchased a 0.32% stake in Dr Reddy’s Laboratories for ₹30.06 crore, as disclosed in a stock exchange filing dated 26 February 2025. The insurer explained that this move aligns with its regular investment activities, stating, “The investment in shares is being made in the ordinary course of the investment […]
Dr Reddy’s Labs gets VAI classification for Andhra Pradesh facility from USFDA – CNBC TV18
[ad_1] Dr Reddy’s Laboratories Ltd on Friday, September 6, announced that it has received an Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh. The inspection has been classified as “Voluntary Action Indicated” (VAI) by the US drug regulator, meaning that while some […]